We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

152 hedge funds and large institutions have $414M invested in Enanta Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 68 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

106% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 33

12% more funds holding

Funds holding: 136 → 152 (+16)

14% less capital invested

Capital invested by funds: $483M → $414M (-$68.5M)

19% less call options, than puts

Call options by funds: $1.63M | Put options by funds: $2M

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
152
Holders Change
+16
Holders Change %
+11.76%
% of All Funds
4.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
31
Increased
68
Reduced
33
Closed
13
Calls
$1.63M
Puts
$2M
Net Calls
-$373K
Net Calls Change
+$6.9M

Top Buyers

1
EC
EcoR1 Capital
California
+$6.69M
2
SAM
Senzar Asset Management
New York
+$4.87M
3
GAM
Gotham Asset Management
New York
+$2.47M
4
NI
Numeric Investors
Massachusetts
+$2.45M
5
AL
AJO LP
Pennsylvania
+$2.44M

Top Sellers

1
Invesco
Invesco
Georgia
-$16.1M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$11.1M
3
O
OrbiMed
New York
-$7.1M
4
MVM
McClain Value Management
Connecticut
-$4.14M
5
WRF
Waddell & Reed Financial
Kansas
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ohio Public Employees Retirement System (OPERS)
76
Ohio Public Employees Retirement System (OPERS)
Ohio
$542K +$176K +6,335 +52%
VRS
77
Virginia Retirement System
Virginia
$540K +$512K +18,400 New
RhumbLine Advisers
78
RhumbLine Advisers
Massachusetts
$539K +$3.06K +110 +0.6%
CIP
79
Convergence Investment Partners
Florida
$533K +$505K +18,148 New
TC
80
TFS Capital
Pennsylvania
$514K +$487K +17,487 New
PA
81
Perceptive Advisors
New York
$514K +$487K +17,507 New
Envestnet Asset Management
82
Envestnet Asset Management
Illinois
$501K +$43.5K +1,562 +10%
ERSOT
83
Employees Retirement System of Texas
Texas
$499K – – –
ProShare Advisors
84
ProShare Advisors
Maryland
$478K -$39.9K -1,433 -8%
Swiss National Bank
85
Swiss National Bank
Switzerland
$468K +$86.3K +3,100 +23%
Stifel Financial
86
Stifel Financial
Missouri
$445K +$15.5K +558 +4%
Comerica Bank
87
Comerica Bank
Texas
$428K +$4.57K +164 +1%
HighTower Advisors
88
HighTower Advisors
Illinois
$428K +$7.24K +260 +2%
Jacobs Levy Equity Management
89
Jacobs Levy Equity Management
New Jersey
$411K +$390K +13,992 New
Citigroup
90
Citigroup
New York
$391K +$294K +10,552 +382%
DCM
91
Dupont Capital Management
Delaware
$386K – – –
SCM
92
Stevens Capital Management
Pennsylvania
$368K +$348K +12,514 New
SSA
93
Schonfeld Strategic Advisors
New York
$356K +$337K +12,108 New
MLICM
94
Metropolitan Life Insurance Company (MetLife)
New York
$342K – – –
AIG
95
American International Group
New York
$341K +$13.5K +484 +4%
BG
96
BlackRock Group
United Kingdom
$327K +$22.8K +819 +8%
FRM
97
Fox Run Management
Connecticut
$317K +$301K +10,800 New
TPSF
98
Texas Permanent School Fund
Texas
$310K -$8.27K -297 -3%
CG
99
Clinton Group
New York
$308K +$292K +10,476 New
State of Tennessee, Department of Treasury
100
State of Tennessee, Department of Treasury
Tennessee
$307K +$6.85K +246 +2%
2 3
4
5 6

ENTA Hedge Fund Activity: Q1 2016 in Review

152 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q1 2016, worth a combined $414M — down 14% from $483M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ENTA positions and 13 closed out — a net gain of 18 holders — while 68 added to existing stakes and 33 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $6.69M. The largest seller was Invesco, cutting an estimated $16.1M.

  • 152 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q1 2016, up from 136 in Q4 2015.
  • Funds reported $414M of Enanta Pharmaceuticals stock for Q1 2016, down 14% quarter-over-quarter.
  • 31 funds opened new Enanta Pharmaceuticals positions in Q1 2016 and 13 closed out, a net change of +18 holders.
  • The largest Enanta Pharmaceuticals buyer in Q1 2016 was EcoR1 Capital, an estimated $6.69M added.
  • The largest Enanta Pharmaceuticals seller in Q1 2016 was Invesco, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2016.